Comments on “Post severe COVID-19 infection lung damages study. The experience of early three months multidisciplinary follow-up” by De Michele et al.
Submitted: January 27, 2022
Accepted: February 18, 2022
Published: March 3, 2022
Accepted: February 18, 2022
Abstract Views: 1175
PDF: 273
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- C. Carbonelli, S. Montepietra, A. Caruso, A. Cavazza, C. Feo, F. Menzella, L. Motti, L. Zucchi, Sarcoidosis and multiple sclerosis: systemic toxicity associated with the use of interferon-beta therapy , Monaldi Archives for Chest Disease: Vol. 77 No. 1 (2012): Pulmonary series
- Elias F. Porto, Antonio A.M. Castro, Daniela M Fausto, Claudia Kümpel, Ana Denise Brandão, Paula Bernardo de Lima, Jordania C. Fagundes, Brenda Zozimo, Balance impairment and lower limbs strength in patients with COPD who fell in the previous year , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- Ayesha Butt, Rashida Ahmed, Muhammad Dawood Amir Sheikh, Omar Khan, Nousheen Iqbal, Arshalooz Jamila Rahman, Javaid Ahmed Khan, Idiopathic pulmonary hemosiderosis - A rare cause of chronic anemia , Monaldi Archives for Chest Disease: Vol. 90 No. 2 (2020)
- Cuneyt Tetikkurt, Haluk Sayman, Selin Ece Dedeoglu, Bahar Kubat, Seza Tetikkurt, Simultaneous use of FDG-18 and 68Ga-citrate PET/CT for the differential diagnosis of sarcoidosis and malignant disease , Monaldi Archives for Chest Disease: Vol. 90 No. 3 (2020)
- Sumita Agrawal, Akhil Dhanesh Goel, Nitesh Gupta, Emerging prophylaxis strategies against COVID-19 , Monaldi Archives for Chest Disease: Vol. 90 No. 1 (2020)
- Kamal Kant Sahu, Ajay Kumar Mishra, Kevin Martin, Iryna Chastain, COVID-19 and restrictive lung disease: A deadly combo to trip off the fine balance , Monaldi Archives for Chest Disease: Vol. 90 No. 2 (2020)
- Soundariya Krishnamurthy, Yuvarajan Sivagnaname, Gokul Chandu Gumallapu, Identification of subclinical cognitive impairment in chronic obstructive pulmonary disease using auditory P300 event related potential , Monaldi Archives for Chest Disease: Vol. 89 No. 2 (2019)
- E. Radzikowska, J. Pawlowski, M. Chabowski, R. Langfort, Constrictive bronchiolitis obliterans in patient with Castelman's disease , Monaldi Archives for Chest Disease: Vol. 63 No. 4 (2005): Pulmonary series
- Nicholas Zareifopoulos, Maria Lagadinou, Anastasia Karela, Christina Platanaki, Gerasimos Karantzogiannis, Dimitrios Velissaris, Management of COVID-19: the risks associated with treatment are clear, but the benefits remain uncertain , Monaldi Archives for Chest Disease: Vol. 90 No. 2 (2020)
- Carlo Uran, Through the heart and beyond: a review on ranolazine , Monaldi Archives for Chest Disease: Vol. 92 No. 1 (2022)
<< < 55 56 57 58 59 60 61 62 63 64 > >>
You may also start an advanced similarity search for this article.